PURE Bioscience, Inc. (PURE)

PURE Bioscience Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.1	3.39	2.39	3.84	0.4
Cash & Cash Equivalents	1.1	3.39	2.39	3.84	0.4
Cash Growth	-67.71%	41.88%	-37.74%	864.57%	-53.23%
Receivables	0.29	0.2	0.37	1.09	0.37
Inventory	0.09	0.18	0.33	0.55	0.18
Other Current Assets	0.14	0.09	0.11	0.09	0.09
Total Current Assets	1.6	3.86	3.2	5.57	1.04
Property, Plant & Equipment	0.22	0.62	0.74	0.32	0.36
Intangible Assets	0	0	0.37	0.44	0.53
Total Long-Term Assets	0.22	0.62	1.11	0.76	0.89
Total Assets	1.83	4.48	4.3	6.32	1.93
Accounts Payable	0.42	0.49	0.59	1.34	0.55
Current Debt	0	0	0.24	0	0
Other Current Liabilities	0.11	0.09	0.14	0.17	0.19
Total Current Liabilities	0.53	0.58	0.97	1.51	0.74
Long-Term Debt	1.02	0	0	0	0
Other Long-Term Liabilities	0	0	0	0	0
Total Long-Term Liabilities	1.02	0	0	0	0
Total Liabilities	1.55	0.58	0.97	1.51	0.74
Total Debt	1.02	0	0.24	0	0
Common Stock	1.12	1.11	0.87	0.87	0.77
Retained Earnings	-133.25	-129.28	-125.79	-123.47	-123.48
Comprehensive Income	0	-0	0	0	-0
Shareholders' Equity	0.27	3.91	3.33	4.81	1.19
Total Liabilities and Equity	1.83	4.48	4.3	6.32	1.93
Net Cash / Debt	0.07	3.39	2.15	3.84	0.4
Net Cash / Debt Growth	-97.82%	57.65%	-43.97%	864.57%	14.37%
Net Cash Per Share	0.00	0.04	0.02	0.05	0.01
Working Capital	1.07	3.29	2.23	4.05	0.3
Book Value Per Share	0.00	0.04	0.04	0.06	0.02

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.